Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Peritumoral and Periganglionic Infiltration of Levobupivacaine Prior to Conservative Surgery for Triple-negative Breast Cancer

NCT07458204 is registered in ClinicalTrials.gov with Institut Jean-Godinot as lead sponsor.

NCT NCT07458204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07458204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Peritumoral and Periganglionic Infiltration of Levobupivacaine Prior to Conservative Surgery for Triple-negative Breast Cancer
Lead sponsor
Institut Jean-Godinot
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
October 1, 2032
Enrollment
760 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

triple-negative breast cancer